α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration

α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration

Proteinaceous inclusions in neurons, composed primarily of α-synuclein, define the pathology in several neurodegenerative disorders. Neurons can internalize α-synuclein fibrils that can seed new inclusions from endogenously expressed α-synuclein. The factors contributing to the spread of pathology a...

Full description

Bibliographic Details
Main Authors:	Hisham Abdelmotilib, Tyler Maltbie, Vedad Delic, Zhiyong Liu, Xianzhen Hu, Kyle B. Fraser, Mark S. Moehle, Lindsay Stoyka, Nadia Anabtawi, Valentina Krendelchtchikova, Laura A. Volpicelli-Daley, Andrew West
Format:	Article
Language:	English
Published:	Elsevier 2017-09-01
Series:	Neurobiology of Disease
Subjects:	NACP SNCA Prion Aggregation Parkinson disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996117301201

Similar Items

Corrigendum to “α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration” [Neurobiol. Dis., Volume 105 (2017) Article 84, 98]
by: Hisham Abdelmotilib, et al.
Published: (2021-11-01)

α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration
by: Ashley S. Harms, et al.
Published: (2017-11-01)

Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
by: Enquan Xu, et al.
Published: (2022-01-01)

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
by: Angeliki Spathopoulou, et al.
Published: (2022-01-01)

A Meta-Analysis of α-Synuclein Multiplication in Familial Parkinsonism
by: Adam Book, et al.
Published: (2018-12-01)

Surface dose measurements and comparison of unflattened and flattened photon beams
by: Ashokkumar Sigamani, et al.
Published: (2016-01-01)

The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease
by: Michael X. Henderson, et al.
Published: (2022-06-01)

Genetic Elements at the Alpha-Synuclein Locus
by: Jordan Prahl, et al.
Published: (2022-07-01)

Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences
by: Dariusz Koziorowski, et al.
Published: (2021-03-01)

Novel multifunctional nanoliposomes inhibit α-synuclein fibrillization, attenuate microglial activation, and silence the expression of SNCA gene
by: A. Jebali, et al.
Published: (2024-05-01)

Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson’s Disease Risk
by: Alix Booms, et al.
Published: (2021-10-01)

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
by: Couch Yvonne, et al.
Published: (2011-11-01)

Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration
by: Nasir Uddin Mahbub, et al.
Published: (2024-02-01)

Alpha‐synuclein dynamics in induced pluripotent stem cell‐derived dopaminergic neurons from a Parkinson’s disease patient (PARK4) with SNCA triplication
by: Hayato Fukusumi, et al.
Published: (2021-02-01)

Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression
by: Sara J. Fagen, et al.
Published: (2023-08-01)

Skin alpha-synuclein deposit patterns: A predictor of Parkinson's disease subtypes
by: Yihang Han, et al.
Published: (2022-06-01)

Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation
by: Katharina Pieger, et al.
Published: (2022-08-01)

Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration
by: Carlo Scialò, et al.
Published: (2019-03-01)

Mutant α-synuclein causes death of human cortical neurons via ERK1/2 and JNK activation
by: Hidefumi Suzuki, et al.
Published: (2024-03-01)

Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson’s disease: a genetic association study
by: Kari Anne Bjørnarå, et al.
Published: (2018-02-01)

Parkinson Hastalığı ve İlişkili Olduğu Genler
by: Yener Kurman
Published: (2018-01-01)

Interaction of Alpha Synuclein and Microtubule Organization Is Linked to Impaired Neuritic Integrity in Parkinson’s Patient-Derived Neuronal Cells
by: Lukas Seebauer, et al.
Published: (2022-02-01)

α-synuclein strains that cause distinct pathologies differentially inhibit proteasome
by: Genjiro Suzuki, et al.
Published: (2020-07-01)

Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease
by: Desiree A. Piper, et al.
Published: (2018-04-01)

Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol
by: Sarah Threlfell, et al.
Published: (2021-04-01)

α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
by: Simon Oliver Hoppe, et al.
Published: (2021-06-01)

The rs3857059 variant of the SNCA gene is associated with Parkinson’s disease in Mexican Mestizos
by: S. García, et al.
Published: (2016-06-01)

Bioinformatic network analysis on the molecular interactions between Parkinson’s disease, alpha-synuclein, and infertility condition
by: Velu Krishnan, et al.
Published: (2023-09-01)

Assessment of Mitochondrial Gene Activity in Dopaminergic Neuron Cultures Derived from Induced Pluripotent Stem Cells Obtained from Parkinson's Disease Patients
by: Anna S. Vetchinova, et al.
Published: (2023-12-01)

Transcriptome Analysis in a Mouse Model of Premature Aging of Dentate Gyrus: Rescue of Alpha-Synuclein Deficit by Virus-Driven Expression or by Running Restores the Defective Neurogenesis
by: Laura Micheli, et al.
Published: (2021-08-01)

A Comprehensive Analysis of the Association Between SNCA Polymorphisms and the Risk of Parkinson's Disease
by: Yuan Zhang, et al.
Published: (2018-10-01)

Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
by: Ningdi Luo, et al.
Published: (2019-05-01)

Prion protein protocols /
by: Hill, Andrew F.
Published: (2008)

Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes
by: Sulev Koks, et al.
Published: (2021-03-01)

Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling
by: Chien-Tai Hong, et al.
Published: (2020-03-01)

Subthalamic deep brain stimulation in Parkinson's disease with SNCA mutations: Based on the follow‐up to 10 years
by: Jinyoung Youn, et al.
Published: (2022-02-01)

The cis-Regulatory Element of SNCA Intron 4 Modulates Susceptibility to Parkinson’s Disease in Han Chinese
by: Shi-Guo Zhu, et al.
Published: (2020-10-01)

Profiling Non-motor Symptoms in Monogenic Parkinson’s Disease
by: Xinyao Liu, et al.
Published: (2020-10-01)

Molecular evolutionary and structural analysis of human UCHL1 gene demonstrates the relevant role of intragenic epistasis in Parkinson’s disease and other neurological disorders
by: Muhammad Saqib Nawaz, et al.
Published: (2020-10-01)

The regulation of exosome function in the CNS: implications for neurodegeneration
by: Francesca Properzi, et al.
Published: (2015-11-01)